These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 2072772)
21. Patterns of nonadherence to antihypertensive therapy in primary care. Grigoryan L; Pavlik VN; Hyman DJ J Clin Hypertens (Greenwich); 2013 Feb; 15(2):107-11. PubMed ID: 23339728 [TBL] [Abstract][Full Text] [Related]
22. Predictors of participant adherence and retention in the African American Study of Kidney Disease and Hypertension. Brooks D; Charleston J; Dowie D; Gabriel A; Hall YB; Hiremath L; Lightfoot T; Sika M; Smith WC; Wang X Nephrol Nurs J; 2008; 35(2):133-42. PubMed ID: 18472682 [TBL] [Abstract][Full Text] [Related]
23. Medication adherence and spiritual perspectives among african american older women with hypertension. A qualitative study. Lewis LM J Gerontol Nurs; 2011 Jun; 37(6):34-41. PubMed ID: 21323238 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa. Sareli P; Radevski IV; Valtchanova ZP; Libhaber E; Candy GP; Den Hond E; Libhaber C; Skudicky D; Wang JG; Staessen JA Arch Intern Med; 2001 Apr; 161(7):965-71. PubMed ID: 11295959 [TBL] [Abstract][Full Text] [Related]
25. Health beliefs and compliance with prescribed medication for hypertension among black women--New Orleans, 1985-86. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1990 Oct; 39(40):701-4. PubMed ID: 2120563 [No Abstract] [Full Text] [Related]
26. Research Needs to Improve Hypertension Treatment and Control in African Americans. Whelton PK; Einhorn PT; Muntner P; Appel LJ; Cushman WC; Diez Roux AV; Ferdinand KC; Rahman M; Taylor HA; Ard J; Arnett DK; Carter BL; Davis BR; Freedman BI; Cooper LA; Cooper R; Desvigne-Nickens P; Gavini N; Go AS; Hyman DJ; Kimmel PL; Margolis KL; Miller ER; Mills KT; Mensah GA; Navar AM; Ogedegbe G; Rakotz MK; Thomas G; Tobin JN; Wright JT; Yoon SS; Cutler JA; Hypertension; 2016 Nov; 68(5):1066-1072. PubMed ID: 27620388 [TBL] [Abstract][Full Text] [Related]
28. Antihypertensive drug compliance in black males. Cook CA J Natl Med Assoc; 1984 Jul; 76 Suppl(Suppl):40-6. PubMed ID: 6471121 [No Abstract] [Full Text] [Related]
29. National heart, lung, and blood institute-initiated program "interventions to improve hypertension control rates in African Americans": background and implementation. Einhorn PT Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):236-40. PubMed ID: 20031843 [No Abstract] [Full Text] [Related]
30. The association of the R563Q genotype of the ENaC with phenotypic variation in Southern Africa. Jones ES; Owen EP; Rayner BL Am J Hypertens; 2012 Dec; 25(12):1286-91. PubMed ID: 22895453 [TBL] [Abstract][Full Text] [Related]
31. Patient characteristics and their influence on therapy and its outcome in hypertension of the elderly. Traub YM; McDonald RH; Shapiro AP Cardiology; 1988; 75(1):45-55. PubMed ID: 3342424 [TBL] [Abstract][Full Text] [Related]
32. From the Centers for Disease Control. Health beliefs, compliance--hypertension. JAMA; 1990 Dec; 264(22):2864. PubMed ID: 2232075 [No Abstract] [Full Text] [Related]
33. Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Black Hypertension Quality of Life Multicenter Trial Group. Croog SH; Kong BW; Levine S; Weir MR; Baume RM; Saunders E Arch Intern Med; 1990 Aug; 150(8):1733-41. PubMed ID: 2200384 [TBL] [Abstract][Full Text] [Related]
34. An RCT of the effect of motivational interviewing on medication adherence in hypertensive African Americans: rationale and design. Ogedegbe G; Schoenthaler A; Richardson T; Lewis L; Belue R; Espinosa E; Spencer J; Allegrante JP; Charlson ME Contemp Clin Trials; 2007 Feb; 28(2):169-81. PubMed ID: 16765100 [TBL] [Abstract][Full Text] [Related]
35. Choosing antihypertensive treatment--models of disease v. RCTs. Edwards PR S Afr Med J; 1995 Nov; 85(11):1190. PubMed ID: 8597015 [No Abstract] [Full Text] [Related]
36. Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function. Merchant N; Searles CD; Pandian A; Rahman ST; Ferdinand KC; Umpierrez GE; Khan BV J Clin Hypertens (Greenwich); 2009 Dec; 11(12):720-5. PubMed ID: 20021529 [TBL] [Abstract][Full Text] [Related]
37. Overcoming barriers to hypertension control in African Americans. Odedosu T; Schoenthaler A; Vieira DL; Agyemang C; Ogedegbe G Cleve Clin J Med; 2012 Jan; 79(1):46-56. PubMed ID: 22219234 [TBL] [Abstract][Full Text] [Related]
38. Marked underestimation of blood pressure control with conventional vs. ambulatory measurements in an urban, developing community of African ancestry. Maseko MJ; Woodiwiss AJ; Majane OH; Molebatsi N; Norton GR Am J Hypertens; 2011 Jul; 24(7):789-95. PubMed ID: 21451594 [TBL] [Abstract][Full Text] [Related]
39. Hypertension Interventions for African American Patients in the Rural South. Grady D; Mody L JAMA Intern Med; 2024 May; 184(5):547. PubMed ID: 38497986 [No Abstract] [Full Text] [Related]
40. Difference in blood pressure response to ACE-Inhibitor monotherapy between black and white adults with arterial hypertension: a meta-analysis of 13 clinical trials. Peck RN; Smart LR; Beier R; Liwa AC; Grosskurth H; Fitzgerald DW; Schmidt BM BMC Nephrol; 2013 Sep; 14():201. PubMed ID: 24067062 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]